Cross-Sector entity

DMEPOS

Product
7

Of the tracked stories, 3 of 3 also mention Centers for Medicare & Medicaid Services, the most common co-covered peer. Coverage clusters in regulation, which accounts for 2 of those 3, with the remainder spread across 1 other category. We currently track 3 Cross-Sector stories that mention DMEPOS, all published on March 6, 2026.

3 verified stories tracked

Last mentioned: Mar 6, 2026

Entity pulse

Recent coverage · DMEPOS

3 stories
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about DMEPOS

Of the tracked stories, 3 of 3 also mention Centers for Medicare & Medicaid Services, the most common co-covered peer. Coverage clusters in regulation, which accounts for 2 of those 3, with the remainder spread across 1 other category. We currently track 3 Cross-Sector stories that mention DMEPOS, all published on March 6, 2026. Each carries 2 original sources on average.

Stories tracked
3
Sources per story
2

Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering DMEPOS. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Initial Expiration

    The first six-month period ends, pending potential CMS extension.

  2. Moratorium Effective Date

    Nationwide freeze on new DMEPOS enrollments officially begins.

  3. Data Review Period Ends

    CMS concludes a multi-year review of high-risk enrollment and claims data.

  4. OIG Fraud Warning

    HHS OIG highlights over a decade of concerns regarding DME supplier fraud.

Stories mentioning DMEPOS 3

Biotech pharma Negative 7

CMS Imposes Unprecedented Nationwide Moratorium on DMEPOS Enrollments

The Centers for Medicare & Medicaid Services (CMS) has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. This aggressive regulatory move, effective February 27, 2026, aims to curb systemic fraud and billions in improper payments within the DMEPOS sector.

2 sources
Healthcare regulation Negative 7

CMS Imposes Unprecedented Nationwide Moratorium on New DMEPOS Enrollments

The Centers for Medicare & Medicaid Services has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. Effective February 27, 2026, this aggressive regulatory action aims to curb systemic fraud and improper payments within the DMEPOS sector.

2 sources